Viewing Study NCT06972758


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2025-12-25 @ 10:10 PM
Study NCT ID: NCT06972758
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-15
First Post: 2025-05-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Adjuvant Everolimus in High-Risk Hepatocellular Carcinoma After Curative Resection (SEVERANCE Trial)
Sponsor: Yonsei University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module